Shaping the future of veterinary medicine through one-time therapies for major chronic pet health conditions.
Scout Bio’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine.
Scout Bio’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine.
Total raised: $20M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.04.2019 | Series B | $20M | - |
Mentions in press and media 10
| Date | Title | Description |
| 09.11.2021 | Scout Bio Named Best New Start-Up for 2021 | IHS Markit recognizes Scout Bio for pioneering therapies in companion animal medicine PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company focused on one-time AAV gene therapies for major chronic pet health con... |
| 09.11.2021 | Scout Bio Named Best New Start-Up for 2021 | PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company focused on one-time AAV gene therapies for major chronic pet health conditions, received top honors as the Best Start-up 2021 from the IHS Markit Animal Heal... |
| 19.10.2021 | Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets | - Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with chronic kidney disease (CKD) - New investors ... |
| 19.10.2021 | Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets | - Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with chronic kidney disease (CKD) - New investors ... |
| 10.04.2019 | Inside the Crazy World of Sports Gambling: Term Sheet for April 10 | PLACE MY BET $8.5 billion. That’s how much Americans will spend betting on college basketball games during March Madness. Paid Content Innovation in payments technology will explode in 2021—and beyond From Visa I covered the sports betting ... |
| 10.04.2019 | Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality | The gene therapy revolution that’s been sweeping through biotech isn’t just about humans anymore. A Penn-partnered biotech called Scout Bio has just picked up a $20 million round to step up its work on once-and-done therapies fo... |
| 10.04.2019 | Daily funding roundup - April 10th, 2019 | Cullgen received $16M; CleverTap raised $26M; Shift secured $40M; ShopBack landed $45M Bump: Bump is a streetwear iOS marketplace app. Bump has raised $7.5 million in Series A funding led by e.ventures, with participation from Kleiner Perki... |
| 10.04.2019 | Scout Bio Raises $20M in Series B Financing | Scout Bio, a Philadelphia, PA-based biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, raised $20m in Series B financing. The round was co-led ... |
| 10.04.2019 | Scout Bio Announces $20M Series B Financing | PHILADELPHIA, PA, Scout Bio announced a $20 million Series B financing. >> Click here for more funding data on Scout Bio >> To export Scout Bio funding data to PDF and Excel, click here Scout Bio, a biotechnology company ... |
| - | Scout Bio raises $20 million in biotech funding | News Scout Bio raises $20 million in biotech funding The new company is going after chronic kidney disease, chronic pain and atopic dermatitis. Written by Today's Veterinary Business in April 2019 The startup company Scout Bio is building a... |